Episode 419: 426. Go Big or Go Partial? The Knee Replacement Showdown

Episode 419: 426. Go Big or Go Partial? The Knee Replacement Showdown

Setting the stage

Picture this: your knee is like a three-room apartment. You've got a medial room, a lateral room, and a patellofemoral room. In isolated anteromedial osteoarthritis, just one room is trashed. The rest of the apartment still looks like something you'd put on a rental listing.

So surgeons have two choices:

Option A: Total knee arthroplasty, or TKA - bulldoze the entire apartment and rebuild it.

Option B: Medial unicompartmental knee arthroplasty, or UKA - fix the one bad room and leave the rest alone.

Previous work suggested that partial knees can actually hold up pretty well when only that medial compartment is involved. But we needed a high-quality, double-blind, multicenter randomized trial to really settle the argument-because if there's anything surgeons love more than power tools, it's being right.

The Danish showdown

Enter Denmark, land of bicycles, universal healthcare, and apparently, a lot of unicompartmental knees. UKA is done more often there than in many other countries, which means they actually have surgeons who are very good at it.

In this new trial, 350 patients with isolated anteromedial osteoarthritis were randomized to either:

Medial unicompartmental knee arthroplasty (UKA), or

Total knee arthroplasty (TKA).

All participating surgeons had substantial experience with both procedures-important, because UKA is more technically demanding. This is not the operation you want someone learning from a YouTube video the night before.

And here's the fun methodological twist: for the first year, both the patients and the evaluators were blinded to which procedure had been done. That's right-people walking around with brand-new metal hardware in their knees, and no one was allowed to know which version they got. It's like the orthopedics version of a mystery box subscription.

What did they measure?

The primary outcome was improvement on a standardized 48-point scale reflecting pain and function over 2 years-essentially, "how good does your knee feel, and what can you do with it?"

They also looked at a bunch of secondary outcomes: different aspects of pain, day-to-day function, range of motion, and so on.

So: same surgeons, similar patients, blinded follow-up, partial versus total. Let's talk results.

Drumroll: who won?

At the 2-year mark:

The average improvement on the primary pain-and-function scale was better with UKA than with TKA.

The mean difference was 3.5 points, and the threshold for "minimal clinically important difference" was considered 4 points. So UKA got very close-call it "clinically almost important, but statistically clearly better."

Avsnitt(385)

Episode 423: 430. Hormone Replacement Therapy and the Black Box Warning

Episode 423: 430. Hormone Replacement Therapy and the Black Box Warning

Let’s rewind to the early 2000s. Flip phones were cool, low-rise jeans were a crime, and the Women’s Health Initiative—WHI—dropped what became the medical equivalent of a headline: “Hormone Therapy In...

24 Mars 12min

Episode 422: 429. Rivaroxaban vs Apixaban = The Battle of the Blood Thinners!

Episode 422: 429. Rivaroxaban vs Apixaban = The Battle of the Blood Thinners!

— rivaroxaban versus apixaban.Yes, folks, this is The Battle of the Blood Thinners!And spoiler alert — one of them came out looking like the overachiever in a safety class... while the other probably ...

20 Mars 9min

Episode 421: 428. Asthma and Stroke --- A breathless combination

Episode 421: 428. Asthma and Stroke --- A breathless combination

Minocycline in Acute Ischemic Stroke (EMPHASIS trial)A multicenter, double-blind RCT in China studied 1,724 patients with acute ischemic stroke treated within 72 hours of onset. Patients received eith...

13 Mars 16min

Episode 420: 427. Kawasaki disease-no, not the motorcycle company

Episode 420: 427. Kawasaki disease-no, not the motorcycle company

Today, we're talking about Kawasaki disease-no, not the motorcycle company, though sometimes treating it does feel like trying to ride one at full speed through uncertainty.For decades, high-dose aspi...

11 Mars 7min

Episode 418: 425. Triptan initiation and cerebrovascular events

Episode 418: 425. Triptan initiation and cerebrovascular events

Kalapura C, et al. Triptan initiation and cerebrovascular events in patients with migraine: A nationwide cohort study. J Am Heart Assoc 2026 Feb 17; 15:e043409. DOI: 10.1161/JAHA.125.043409.  Today, w...

6 Mars 6min

Episode 417: 424. GLP1 and NAION

Episode 417: 424. GLP1 and NAION

Li H-Y, et al. GLP-1 receptor agonists and risk of optic nerve or vision-threatening events in patients with type 2 diabetes or cardiometabolic diseases: A meta-analysis of randomized controlled trial...

5 Mars 8min

Episode 416: 423. CME-- Discharge Questions Answered in 2025

Episode 416: 423. CME-- Discharge Questions Answered in 2025

CME-- Discharge Questions Answered in 2025

3 Mars 45min

Populärt inom Hälsa

somna-med-henrik
rss-bara-en-till-om-missbruk-medberoende-2
inga-beiga-morsor
rss-jossan-nina
alska-oss
rss-vuxna-pa-latsas
sexnoveller-deluxe
angestpodden
not-fanny-anymore
sova-med-dan-horning
johannes-hansen-podcast
rss-viktmedicinpodden
brottarbroder
vinterpasset
sa-in-i-sjalen
sag-det-bara
rss-sjalsligt-avkladd
rss-the-house-podcast-3
giggles-med-wiggles
till-sangs